Clinical efficacy of new antifungal agents

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · see citing works

Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases

Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M. T., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,048 · see citing works

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380 · see citing works

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979 · see citing works

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 905 · see citing works

Voriconazole: A New Triazole Antifungal Agent

Johnson, L. B., & Kauffman, C. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367933 · Cited by 782 · see citing works

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

van Burik, J. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 741 · see citing works

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., Dupont, B., Torre‐Cisneros, J., Just‐Nübling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 672 · see citing works

Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H. M., Champlin, R. E., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 672 · see citing works

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

Maertens, J., RAAD, I. I., Petrikkos, G. L., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A. L., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 651 · see citing works

Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases

van Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/500212 · Cited by 614 · see citing works

Posaconazole as Salvage Therapy for Zygomycosis

Greenberg, R. N., Mullane, K. M., van Burik, J. H., RAAD, I. I., Abzug, M. J., Anstead, G. M., Herbrecht, R., Langston, A. A., Marr, K. A., Schiller, G. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 552 · see citing works

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521 · see citing works

Infections Due to Scedosporium apiospermum and Scedosporium prolificans in Transplant Recipients: Clinical Characteristics and Impact of Antifungal Agent Therapy on Outcome

Husain, S., Munoz, P., Forrest, G. N., Alexander, B. D., Somani, J., Brennan, K., Wagener, M. M., & Singh, N. (2004) · Clinical Infectious Diseases · doi:10.1086/426445 · Cited by 402 · see citing works

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

Schwartz, S. (2005) · Blood · doi:10.1182/blood-2005-02-0733 · Cited by 391 · see citing works

Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients

Nucci, M., Marr, K. A., Queiroz‐Telles, F., Martins, C. A. S., Trabasso, P., Costa, S. F., Voltarelli, J. C., Colombo, A. L., Imhof, A., Pasqüini, R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383319 · Cited by 332 · see citing works

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

RAAD, I. I., Hachem, R. Y., Herbrecht, R., Graybill, J. R., Hare, R. S., Corcoran, G., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/503425 · Cited by 299 · see citing works

Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases

Steinbach, W. J., Benjamin, D. K., Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H. S., & Walsh, T. J. (2004) · Clinical Infectious Diseases · doi:10.1086/421950 · Cited by 294 · see citing works

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

Denning, D. W., Marr, K. A., Lau, W. M., Facklam, D., Ratanatharathorn, V., Becker, C., Ullmann, A. J., Seibel, N. L., Flynn, P. M., van Burik, J. H., et al. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.03.003 · Cited by 293 · see citing works

Posaconazole: a broad-spectrum triazole antifungal

Torres, H. A., Hachem, R. Y., Chemaly, R. F., Kontoyiannis, D. P., & RAAD, I. I. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70297-8 · Cited by 287 · see citing works

Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

Ullmann, A. J., Cornely, O. A., Burchardt, A. C., Hachem, R. Y., Kontoyiannis, D. P., Toepelt, K., Courtney, R., Wexler, D. B., Krishna, G., Martinho, M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.658-666.2006 · Cited by 271 · see citing works

Micafungin: A New Echinocandin

Chandrasekar, P. H., & Sobel, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/501020 · Cited by 255 · see citing works

Activity of posaconazole in the treatment of central nervous system fungal infections

Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P. G., Chapman, S. W., Hare, R. S., & Hardalo, C. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki288 · Cited by 249 · see citing works

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Seibel, N. L., Schwartz, C. L., Arrieta, A. C., Flynn, P. M., Shad, A. T., Albano, E., Keirns, J. J., Lau, W. M., Facklam, D., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 241 · see citing works

Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

Moudgal, V. V., Little, T., Boikov, D. A., & Vázquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 241 · see citing works

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Benjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 209 · see citing works

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

Krogh-Madsen, M., Arendrup, M. C., Heslet, L., & Knudsen, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/500939 · Cited by 201 · see citing works

Zygomycosis: Reemergence of an Old Pathogen

Kauffman, C. A. (2004) · Clinical Infectious Diseases · doi:10.1086/422729 · Cited by 178 · see citing works

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

Krause, D. S., Reinhardt, J. F., Vázquez, J. A., Reboli, A. C., Goldstein, B. P., Wible, M., & Henkel, T. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2021-2024.2004 · Cited by 177 · see citing works

A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

Vázquez, J. A., Skiest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J. P., Greaves, W. L., & ISAACS, R. E. (2006) · Clinical Infectious Diseases · doi:10.1086/501457 · Cited by 171 · see citing works

Treatment of Non-Aspergillus Moulds in Immunocompromised Patients, with Amphotericin B Lipid Complex

Perfect, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429331 · Cited by 167 · see citing works

Caspofungin Resistance in<i>Candida albicans</i>: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

Hernandez, S., López-Ribot, J. L., Najvar, L. K., McCarthy, D. I., Bocanegra, R., & Graybill, J. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1382-1383.2004 · Cited by 162 · see citing works

Salvage treatment of histoplasmosis with posaconazole

Restrepo, Á., Tobón, Á. M., Clark, B., Graham, D. R., Corcoran, G., Bradsher, R. W., Goldman, M., Pankey, G. A., Moore, T., Negroni, R., et al. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.05.006 · Cited by 149 · see citing works

Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center

Freifeld, A. G., Iwen, P. C., Lesiak, B., Gilroy, R. K., Stevens, R. B., & Kalil, A. C. (2005) · Transplant Infectious Disease · doi:10.1111/j.1467-8365.2005.00105.x · Cited by 144 · see citing works

Erratum: Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases (Clinical Infectious Diseases (April 1, 2006) 42 (e61-e65))

van Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · Cited by 140 · see citing works

Voriconazole for Invasive Bone Aspergillosis: A Worldwide Experience of 20 Cases

Mouas, H., Lutsar, I., Dupont, B., Fain, O., Herbrecht, R., Lescure, F.-X., Lortholary, O., & The Voriconazole/Bone Invasive Aspergillosis Study Group (2005) · Clinical Infectious Diseases · doi:10.1086/428734 · Cited by 126 · see citing works

Refractory Coccidioidomycosis Treated with Posaconazole

Anstead, G. M., Corcoran, G., Lewis, J., Berg, D., & Graybill, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/430303 · Cited by 123 · see citing works

Successful Treatment of Coccidioidal Meningitis with Voriconazole

Cortez, K. J., Walsh, T. J., & Bennett, J. E. (2003) · Clinical Infectious Diseases · doi:10.1086/375235 · Cited by 112 · see citing works

Successful Use of Voriconazole for Treatment of Coccidioides Meningitis

Proia, L. A., & Tenorio, A. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2341.2004 · Cited by 86 · see citing works

Successful Treatment of Cerebral Blastomycosis with Voriconazole

Bakleh, M., Aksamit, A. J., Tleyjeh, I. M., & Marshall, W. F. (2005) · Clinical Infectious Diseases · doi:10.1086/429319 · Cited by 76 · see citing works

Successful Treatment of Disseminated Nonmeningeal Coccidioidomycosis with Voriconazole

Prabhu, R. M., Bonnell, M. R., Currier, B. L., & Orenstein, R. (2004) · Clinical Infectious Diseases · doi:10.1086/424019 · Cited by 66 · see citing works

A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole

Clark, B., Foster, R., Tunbridge, A., & Green, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.001 · Cited by 44 · see citing works

Chitosan, the Deacetylated Form of Chitin, Is Necessary for Cell Wall Integrity in Cryptococcus neoformans

Baker, L. G., Specht, C. A., Donlin, M. J., & Lodge, J. K. (2007) · Eukaryotic Cell · doi:10.1128/ec.00399-06 · Cited by 379 · see citing works

Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285 · see citing works

Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases

Nami, S., Aghebati‐Maleki, A., Morovati, H., & Maleki, L. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.009 · Cited by 162 · see citing works

Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients

Barnes, P. D., & Marr, K. A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06812.x · Cited by 151 · see citing works

Antifungal serum concentration monitoring: an update

Goodwin, M. L., & Drew, R. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm389 · Cited by 136 · see citing works

Cell Wall Chitosan Is Necessary for Virulence in the Opportunistic Pathogen Cryptococcus neoformans

Baker, L. G., Specht, C. A., & Lodge, J. K. (2011) · Eukaryotic Cell · doi:10.1128/ec.05138-11 · Cited by 125 · see citing works

Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

Auberger, J., Lass‐Flörl, C., Ulmer, H., Nogler-Semenitz, E., Clausen, J., Gunsilius, E., Einsele, H., Gastl, G. A., & Nachbaur, D. (2008) · International Journal of Hematology · doi:10.1007/s12185-008-0184-2 · Cited by 105 · see citing works

Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin

El-Ridy, M. S., Abdelbary, A., Essam, T. M., Abdelsalam, R. M., & Kassem, A. A. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.587431 · Cited by 100 · see citing works

When Primary Antifungal Therapy Fails

Nucci, M., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/587101 · Cited by 98 · see citing works

Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment

Arndt, S., Aschendorff, A., Echternach, M., Dämmrich, T., & Maier, W. (2008) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-008-0692-y · Cited by 71 · see citing works

Conformational Analysis of Macrocycles: Finding What Common Search Methods Miss

Bonnet, P., Agrafiotis, D. K., Zhu, F., & Martin, É. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900238a · Cited by 67 · see citing works

In search of the holy grail of antifungal therapy.

Chapman, S. W., Sullivan, D. C., & Cleary, J. D. (2008) · PubMed Central · Cited by 64 · see citing works

Severe filamentous fungal infections after widespread tissue damage due to traumatic injury: Six cases and review of the literature

Vitrat-Hincky, V., Lebeau, B., Bozonnet, E., Falcon, D., Pradel, P., Faure, O., Aubert, A., Piolat, C., Grillot, R., & Pelloux, H. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902856537 · Cited by 62 · see citing works

Invasive fungal infections in transplant recipients

Vázquez, J. A., Miceli, M. H., & Alangaden, G. J. (2013) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936113491936 · Cited by 63 · see citing works

Evaluation of the antifungal potential of Brazilian Cerrado medicinal plants

Silva, F. M. E., de Paula, J. E., & Espíndola, L. S. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01647.x · Cited by 59 · see citing works

Aggressive Cutaneous Squamous Cell Carcinoma Associated with Prolonged Voriconazole Therapy in a Renal Transplant Patient

Vanacker, A., Fabré, G., Dorpe, J. V., Peetermans, W. E., & Maes, B. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02140.x · Cited by 57 · see citing works

Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients

Stelzmueller, I., Lass‐Flörl, C., Geltner, C., Graziadei, I. W., Schneeberger, S., Antretter, H., Mueller, L., Zelger, B. G., Singh, N., Pruett, T. L., et al. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00657.x · Cited by 56 · see citing works

Cch1 Restores Intracellular Ca2+ in Fungal Cells during Endoplasmic Reticulum Stress

Hong, M.-P., Vu, K., Bautos, J., & Gelli, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056218 · Cited by 54 · see citing works

Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh)

Flammer, K., Nettifee, J. A., Webb, D. J., Foster, L., Dillard, S. L., & Davis, J. L. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.1.114 · Cited by 51 · see citing works

Mucor circinelloides Was Identified by Molecular Methods as a Cause of Primary Cutaneous Zygomycosis

Iwen, P. C., Sigler, L., Noel, R. K., & Freifeld, A. G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01907-06 · Cited by 45 · see citing works

Posaconazole

Frampton, J. E., & Scott, L. J. (2008) · Drugs · doi:10.2165/00003495-200868070-00008 · Cited by 43 · see citing works

Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges

Παπαδοπούλου, Α., Kaloyannidis, P., Yannaki, E., & Cruz, C. C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.005 · Cited by 41 · see citing works

Chitinases Are Essential for Sexual Development but Not Vegetative Growth in Cryptococcus neoformans

Baker, L. G., Specht, C. A., & Lodge, J. K. (2009) · Eukaryotic Cell · doi:10.1128/ec.00227-09 · Cited by 36 · see citing works

Multilaboratory Testing of Antifungal Combinations against a Quality Control Isolate of Candida krusei

Chaturvedi, V. P., Ramani, R., Ghannoum, M. A., Killian, S. B., Holliday, N. M., Knapp, C. C., Ostrosky‐Zeichner, L., Messer, S. A., Pfaller, M. A., Iqbal, N. J., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-07 · Cited by 34 · see citing works

Infection of the subcutis of the nose in a cat caused by Mucor species: Successful treatment using posaconazole

Wray, J., Sparkes, A., & Johnson, E. (2008) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2008.06.001 · Cited by 31 · see citing works

Posaconazole

Kauffman, C. A., Malani, A. N., Easley, C., & Kirkpatrick, P. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2270 · Cited by 29 · see citing works

The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance

Islam, M. R., Rahman, M. M., Islam, M. R., Sarkar, N., Akash, S., Islam, M., Islam, F., Aktar, M. N., Saeed, M., Harun-Or-Rashid, M., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22204-8 · Cited by 30 · see citing works

Astemizole and an analogue promote fungicidal activity of fluconazole againstCryptococcus neoformansvar.grubiiandCryptococcus gattii

Vu, K., & Gelli, A. (2010) · Medical Mycology · doi:10.3109/13693780903081968 · Cited by 28 · see citing works

Antifungal Resistance Mechanisms of Aspergillus

Qiao, J., Liu, W. Y., & Li, R. (2008) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.49.157 · Cited by 26 · see citing works

Infectious Arthritis of Native Joints

Ohl, C. A., & Forster, D. W. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00105-3 · Cited by 25 · see citing works

Design and synthesis of 1,3,5-trisubstituted 1,2,4-triazoles as CYP enzyme inhibitors

Al‐Soud, Y. A., Heydel, M., & Hartmann, R. W. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.09.049 · Cited by 24 · see citing works

Enantiopure Triazolium Salts: Chemoenzymatic Synthesis and Applications in Organocatalysis

Ríos‐Lombardía, N., Porcar, R., Busto, E., Alfonso, I., Montejo-Bernardo, J. M., García‐Granda, S., Gotor, V., Luis, S. V., García‐Verdugo, E., & Gotor‐Fernández, V. (2011) · ChemCatChem · doi:10.1002/cctc.201100218 · Cited by 20 · see citing works

1,2,4-Triazoles

Curtis, A. D. M., & Jennings, N. S. (2008) · Elsevier eBooks · doi:10.1016/b978-008044992-0.00502-2 · Cited by 20 · see citing works

Xenobiotic Efflux in Bacteria and Fungi: A Genomics Update

Barabote, R. D., Thekkiniath, J., Strauss, R. E., Vediyappan, G., Fralick, J. A., & Francisco, M. J. S. (2011) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470920541.ch6 · Cited by 20 · see citing works

Modes of action

Chopra, I. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00002-6 · Cited by 20 · see citing works

Effects of propiconazole on extra-cellular enzymes involved in nutrient mobilization during Trametes versicolor wood colonization

Lekounougou, S., Jacquot, J., Gérardin, P., & Gelhaye, É. (2007) · Wood Science and Technology · doi:10.1007/s00226-007-0158-1 · Cited by 17 · see citing works

The current role of amphotericin B lipid complex in managing systemic fungal infections

Chu, P., & Sadullah, S. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903379077 · Cited by 16 · see citing works

Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis

Meletiadis, J., Andes, D. R., Lockhart, S. R., Ghannoum, M. A., Knapp, C. C., Ostrosky‐Zeichner, L., Pfaller, M. A., Chaturvedi, V. P., & Walsh, T. J. (2022) · Journal of Fungi · doi:10.3390/jof8090967 · Cited by 13 · see citing works

Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures

Nguyen, K. Q., Hawkins, M. G., Taylor, I. T., Wiebe, V. J., & Tell, L. A. (2009) · American Journal of Veterinary Research · doi:10.2460/ajvr.70.7.908 · Cited by 13 · see citing works

TheYTA7gene is involved in the regulation of the isoprenoid pathway in the yeastSaccharomyces cerevisiae

Kuranda, K., Grabińska, K. A., Bergès, T., Karst, F., Berre, V. L., Sokol, S., François, J., & Palamarczyk, G. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00485.x · Cited by 11 · see citing works

In vitro activity of caspofungin and voriconazole against uncommon Candida spp.

Angoulvant, A., Girard, A., POIROT, J. L., & Hennequin, C. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.002 · Cited by 9 · see citing works

Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations

Maki, K., Holmes, A. R., Watabe, E., Iguchi, Y., Matsumoto, S., Ikeda, F., Tawara, S., & Mutoh, S. (2007) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2007.tb04000.x · Cited by 9 · see citing works

Infectious Arthritis of Native Joints

Ohl, C. A. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00102-8 · Cited by 7 · see citing works

Understanding the fundamental role of virulence determinants to combat Aspergillus fumigatus infections: exploring beyond cell wall

Gupta, L., Hoda, S., Vermani, M., & Vijayaraghavan, P. (2021) · Mycological Progress · doi:10.1007/s11557-021-01677-w · Cited by 6 · see citing works

Vesicular nanocarriers: An innovative targeted and sustained drug delivery system

Gomathi, R., Bharathiraja, A., Sabitha, V., Snekha, K., Susmitha, R., Gokulram, P., & Selvasudha, N. (2026) · Next Bioengineering · doi:10.1016/j.nxbio.2026.100024 · Cited by 4 · see citing works

Asymmetric synthesis of azolium-based 1,2,3,4-tetrahydronaphthalen-2-ols through lipase-catalyzed resolutions

Méndez‐Sánchez, D., Ríos‐Lombardía, N., Gotor, V., & Gotor‐Fernández, V. (2015) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2015.06.006 · Cited by 4 · see citing works

Isolation of Major Components from the Roots of Godmania aesculifolia and Determination of Their Antifungal Activities

Tamayo‐Castillo, G., Vásquez, V., Rios, M. Y., Rodriguez, M. V., Solano, G., Zacchino, S. A., & Gupta, M. P. (2013) · Planta Medica · doi:10.1055/s-0033-1351025 · Cited by 3 · see citing works

Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation

Dornbusch, H. J., Sovinz, P., Lackner, H., Schwinger, W., Benesch, M., Strenger, V., & Urban, C. E. (2008) · Medical Mycology · doi:10.1080/13693780801930746 · Cited by 2 · see citing works

Perfil fenotípico e de expressão de proteínas de Cryptococcus neoformans após tratamento com substâncias obtidas da planta Pterogyne nitens

Sangalli-Leite, F. (2010) · doi:10.5016/dt000618647 · Cited by 2 · see citing works

Essential Genes inAspergillus fumigatus

Hu, W., Jiang, B., & Roemer, T. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch5 · Cited by 1 · see citing works

Opportunistische Mykosen

Jelinek, T. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-22073-9.00059-0

Cryptococcus neoformans Development but Not Vegetative Growth in Chitinases Are Essential for Sexual

Baker, L. G., Specht, C. A., & Lodge, J. K. (2013)

Morphological and ultrastructural changes induced by essential oil of Melaleuca alternifolia on drug-sensitive and drug-resistant strains of Candida albicans

Colone, M., Mastrangelo, N., Mondello, F., Toccacieli, L., Cerqua, L., & Stringaro, A. (2011) · doi:10.4081/microscopie.2011.4979

Opportunistische Mykosen

Jelinek, T. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50460-x

Infektionen an Vulva, Vagina und Zervix

Friese, K. (2009)

Mucocutaneus candidiasis. A revision

Villanueva-Reyes, J. D. P., & Arenas, R. (2007)

Vias alternativas mitocondriais: estudos moleculares e bioquímicos de uma UCP-like de Aspergillus fumigatus

Cardoso, F. G. (2017) · doi:10.11606/d.17.2017.tde-08012016-124834

Antifungal tedavide son gelişmeler

Kaan, K. (2008) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000491

Echinocandins

Perlin, D. S., & Hope, W. W. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_16

Mycoses

Kim, A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00124-7

Infektionskrankheiten und Schutzimpfungen

(2011) · Elsevier eBooks · doi:10.1016/b978-3-437-22702-8.50016-9

Assessment of the antifungal susceptibility profile and virulence factors of non-albicans candida species obtained from the infection of the bloodstream

Goel, R., Anusha, P., Rangari, A. A., & Adhikary, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.12991

Systemische Mykosen

Jelinek, T. (2023) · Elsevier eBooks · doi:10.1016/b978-3-437-23817-8.00068-9

The diagnosis and management of systemic candidiasis in the Intensive Care Unit

Big, C., & Vazquez, J. A. (2015)

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

Fera, M. T., Camera, E. L., & Sarro, A. D. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.67 · Cited by 134 · see citing works

Efficacies and Clinical Roles of New Antifungal Agents

Tokimatsu, I., & Kadota, J. (2006) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.47.155

Newer Systemic Antifungal Agents

Boucher, H. W., Groll, A. H., Chiou, C. C., & Walsh, T. J. (2004) · Drugs · doi:10.2165/00003495-200464180-00001 · Cited by 308 · see citing works

Neue Medikamente zur Behandlung systemischer Mykosen

SCHEDEL, I. (2005) · Der Internist · doi:10.1007/s00108-005-1413-x

Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage

Spanakis, E. K., Aperis, G., & Mylonakis, E. E. (2006) · Clinical Infectious Diseases · doi:10.1086/507891 · Cited by 166 · see citing works